Clinical trial

STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

NCT07631156

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-12

PhasePHASE4

Study timeline

Study start (actual)2026-08-12Date precision: day

Registry last updated2026-09-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Heart Failureunresolved

Ventricular Dysfunction, Leftunresolved

Interventions

Stepwise Withdrawal of ARNI and SGLT2iDRUG

Continued Guideline-Directed Medical TherapyDRUG

Sponsors & collaborators

Kyungsub Songlead sponsor

Seoul National University Bundang Hospitalcollaborator

Ajou University School of Medicinecollaborator

Korea University Anam Hospitalcollaborator

Pusan National University Yangsan Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07631156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.